A $5.3 billion deal that sent interest soaring in the AI global cyber security sector just 15 months ago when Thoma Bravo in the US bought Cambridge's Darktrace, has already thrown up an issue over ...

The global power and potential of Cambridge’s Granta Park as an influencer of life science innovation is highlighted in new ...

As part of its plan to implement last year’s Keep Britain Working Report, the Government is re-vamping the Disability Confident Scheme, which will reach its tenth anniversary at the end of this year.

Railpen, manager of the £34 billion Railways Pension Scheme in the UK, has achieved a BREEAM ‘Outstanding’ design-stage score ...

Cambridge-based Blighter Surveillance Systems, which designs and makes electronic scanning ground surveillance radars, is ...

Reflections of this month’s JP Morgan Week when many of the Life Sciences world of companies, investors and commentators ...

Cambridge company TeraView, a pioneer and leader in terahertz technology and solutions, has become the first UK and probably ...

AstraZeneca has announced plans to invest $15 billion in China to pioneer the next-generation of innovative medicines. CEO ...

The life sciences outlook for 2026 is being shaped by three interlocking forces, writes Paul Hughes, Managing Director, Life Sciences & Technology, BDO LLP.

The UK biotech sector continues to demonstrate a quiet but determined resilience, even as investors navigate more cautious global market conditions, writes Zickie Lim, Partner and Head of Venture ...

Wellcome Sanger Institute Senior Group Leader, and former Institute Director, Professor Sir Mike Stratton has been awarded the 2026 Jessie Stevenson Kovalenko Medal by the Council of the National ...

Cambridge Science Park is expanding its leadership team, strengthening its critical role and future ambition at the centre of ...